Inventor · disambiguated record
Pierangelo Geppetti
Also filed as: GEPPETTI PIERANGELO
6 granted patents·5 pending applications·5 citations·filing 2003–2022
68Inventor score
Files withPHARMESTE SRL4FLONEXT S R L3BARALDI PIER GIOVANNI1GEPPETTI PIERANGELO1PATACCHINI RICCARDO1
Top patents by PatentIndex Score
11 records- 0177US7919624B2VR1 vanilloid receptor antagonists with a iononic substructurePHARMESTE SRL·Filed 2007·Granted Apr 5, 2011·5 cites·27 claims
- 0258US2025043280A1Antisense oligonucleotide for use in the treatment of psoriasis-induced itching and phospholipid vesicle comprising said oligonucleotideFLONEXT S R L·Filed 2022·Application pending·0 cites
- 0356US2004143014A1Therapeutic use of alpha-2-delta ligandsPFIZER·Filed 2003·Application pending·0 cites
- 0453US2024269115A1Pyrazolone compounds for use in degenerative retinal diseasesFLONEXT S R L·Filed 2022·Application pending·0 cites
- 0553US2024285623A1Trpa1 channel antagonist compound for use in degenerative retinal diseasesFLONEXT S R L·Filed 2022·Application pending·0 cites
- 0647US7964642B2Vanilloid TRPV1 receptor antagonistsPHARMESTE SRL·Filed 2005·Granted Jun 21, 2011·0 cites·7 claims
- 0746US8222275B2Biarylcarboxyarylamides as vanilloid-1 receptor modulatorsBARALDI PIER GIOVANNI·Filed 2007·Granted Jul 17, 2012·0 cites·27 claims
- 0844US7750049B2O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonistsPHARMESTE SRL·Filed 2007·Granted Jul 6, 2010·0 cites·18 claims
- 0942US7579378B2Sulfonamido compounds that antagonize the vanilloid TRPV1 receptorPHARMESTE SRL·Filed 2005·Granted Aug 25, 2009·0 cites·23 claims
- 1032US8492396B2Therapeutic uses of adrenergic α-1 receptor antagonistsGEPPETTI PIERANGELO·Filed 2010·Granted Jul 23, 2013·0 cites·3 claims
- 1129US2012101076A1Carbonate derivatives for the treatment of coughPATACCHINI RICCARDO·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pierangelo Geppetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →